GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed Price. Currency in GBp
1,653.50-5.00 (-0.30%)
As of 8:27 AM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1,658.50
Bid1,652.50 x 175400
Ask1,653.50 x 417900
Day's Range1,628.92 - 1,655.50
52wk Range1,227.50 - 1,716.50
1y Target EstN/A
Market Cap80.11B
P/E Ratio (ttm)2,755.83
Avg Vol (3m)8,649,373
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Benzinga17 hours ago

    Waiting For Growth, Or A Better Valuation, Argus Stays Sidelined On Novartis Shares

    Argus maintained its Hold rating on Novartis AG (ADR) (NYSE: NVS ) as it looks for a favorable entry point. However, the brokerage's long-term rating on the stock is Buy as many of the drugs under development ...

  • Capital Cube21 hours ago

    ETF’s with exposure to GlaxoSmithKline Plc : August 24, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to GlaxoSmithKline Plc Here are 5 ETF’s with the largest exposure to GSK-GB. Comparing the performance and risk of GlaxoSmithKline Plc with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • GlaxoSmithKline Plc :GSK-GB: Earnings Analysis: Q2, 2016 By the Numbers : August 23, 2016
    Capital Cube2 days ago

    GlaxoSmithKline Plc :GSK-GB: Earnings Analysis: Q2, 2016 By the Numbers : August 23, 2016

    Categories: Yahoo Finance Get free summary analysis GlaxoSmithKline Plc reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of GlaxoSmithKline Plc – AstraZeneca PLC, Shire PLC and GW Pharmaceuticals PLC (AZN-GB, SHP-GB and GWP-GB) that have also reported for this period. Highlights Summary numbers: Revenues of GBP 6532 ... Read more (Read more...)